Biodyne Co. Ltd. (314930.KQ) stock: key figures, P/E, revenue and dividend
Energy · Coal & Consumable Fuels · South Korea
Biodyne Co. Ltd. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 5.27 bn KRW | 7.03 bn KRW |
| Gross profit | 2.44 bn KRW | 4.47 bn KRW |
| Operating income | -1.73 bn KRW | 652.26 m KRW |
| EBIT | -140.92 m KRW | 831.58 m KRW |
| Net income | 10.77 m KRW | 851.59 m KRW |
| Diluted EPS – continuing operations | 0.37 KRW | 28.89 KRW |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Biodyne Co. Ltd.
Biodyne Co., Ltd. engages in the development, manufacture, and sale of liquid-based cytology (LBC) equipment and reagent kits for cancer diagnosis in South Korea. The company offers PATHPLORER solution, which preserves and fixes the collected cells; PATHPLORER LBC system, an equipment for processing liquid cytology samples for cancer diagnosis. It exports its products to Japan, Russia, Portugal, Thailand, and internationally. The company was founded in 1999 and is headquartered in Seoul, South Korea.
More stocks
- Daios Plastics S.A. (DAIOS.AT)
- Tah Kong Chemical Industrial (4706.TWO)
- John Hancock Income Securities Closed Fund (JHS)
- Founding Construction Development Co Ltd (5533.TW)
- Cynca Nordic AB (publ) (CYNCA.ST)
- Peoples Ltd (PPLL)
- Chosun Refractories Co Ltd (000480.KS)
- GOWell Energy Technology Ordinary shares (GOW)
- NEW PEOPLES BANKSHARES INC (NWPP)
- Thai Kin Co. Ltd (6629.TWO)
- Noroo Paint (090350.KS)
- ASCENT INDUSTRIES CO. (ACNT)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.